Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001123292-18-001115

Options or other derivatives

  • Chief Accounting Officer acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

VandenEnden Koert · Chief Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-11 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +7,500 7,500 D
Loading xslF345X03/edgar.xml…